Neuren Pharmaceuticals Limited
NURPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $142,043 | $157,081 | $184 | -$7,794 |
| Dep. & Amort. | $0 | $17 | $10 | $8 |
| Deferred Tax | $0 | -$2,928 | -$1,475 | -$3,476 |
| Stock-Based Comp. | $0 | $0 | $1,988 | $840 |
| Change in WC | -$157,585 | $23,237 | $533 | -$2,620 |
| Other Non-Cash | $4,272 | $7,518 | $2,359 | $3,072 |
| Operating Cash Flow | -$11,270 | $184,925 | $3,599 | -$9,970 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10 | -$40 | -$19 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$211,445 | $0 | $0 |
| Inv. Sales/Matur. | $4,144 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4,134 | -$211,485 | -$19 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,660 | $3,619 | $0 | $23,281 |
| Stock Repurch. | -$10,426 | $0 | -$2 | -$1,106 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$2 | $0 |
| Financing Cash Flow | -$8,775 | $3,619 | -$2 | $22,175 |
| Forex Effect | $1,970 | -$145 | -$181 | $400 |
| Net Chg. in Cash | -$13,941 | -$23,086 | $3,397 | $12,595 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,094 | $40,180 | $36,783 | $24,188 |
| End Cash | $3,153 | $17,094 | $40,180 | $36,783 |
| Free Cash Flow | -$11,280 | $184,885 | $3,580 | -$9,980 |